SARS-CoV-2 Omicron Induces Enhanced Mucosal Interferon Response Compared to other Variants of Concern, Associated with Restricted Replication in Human Lung Tissues

SARS-CoV-2 Omicron variant has been characterized by decreased clinical severity, raising the question of whether early variant-specific interactions within the mucosal surfaces of the respiratory tract could mediate its attenuated pathogenicity. Here, we employed ex vivo infection of native human n...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfi, Or, Hamdan, Marah, Wald, Ori, Yakirevitch, Arkadi, Wandel, Ori, Oiknine-Djian, Esther, Gvili, Ben, Knoller, Hadas, Rozendorn, Noa, Golan Berman, Hadar, Adar, Sheera, Vorontsov, Olesya, Mandelboim, Michal, Zakay-Rones, Zichria, Oberbaum, Menachem, Panet, Amos, Wolf, Dana G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318963/
https://www.ncbi.nlm.nih.gov/pubmed/35891570
http://dx.doi.org/10.3390/v14071583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318963/
https://www.ncbi.nlm.nih.gov/pubmed/35891570
http://dx.doi.org/10.3390/v14071583

Ejemplares similares